Anti-egfr/c-met Bispecific Antibody Emb-01

Anti-egfr/c-met Bispecific Antibody Emb-01 Uses, Dosage, Side Effects, Food Interaction and all others data.

Anti-egfr/c-met Bispecific Antibody Emb-01 is under investigation in clinical trial NCT03797391 (A Dose Escalation Study of Anti-egfr/c-met Bispecific Antibody Emb-01 in Participants With Advanced/metastatic Solid Tumors).

Trade Name Anti-egfr/c-met Bispecific Antibody Emb-01
Generic EMB-01
EMB-01 Other Names Anti-egfr/anti-c-met bispecific antibody emb-01, Anti-egfr/c-met bispecific antibody emb-01
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Anti-egfr/c-met Bispecific Antibody Emb-01
Anti-egfr/c-met Bispecific Antibody Emb-01

Innovators Monograph

You find simplified version here Anti-egfr/c-met Bispecific Antibody Emb-01


*** Taking medicines without doctor's advice can cause long-term problems.
Share